Detection of Familial Hypercholesterolemia Using Next Generation Sequencing in Two Population-Based Cohorts

논문상세정보
    • 저자 김희남 권순석 신민호
    • 제어번호 105059397
    • 학술지명 전남의대학술지
    • 권호사항 Vol. 54 No. 1 [ 2018 ]
    • 발행처 전남대학교 의과학연구소
    • 자료유형 학술저널
    • 수록면 31-35
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 경북대학교 도서관 의학분관 영남대학교 의료원 의학도서관
    • 판매처
    유사주제 논문( 0)

' Detection of Familial Hypercholesterolemia Using Next Generation Sequencing in Two Population-Based Cohorts' 의 참고문헌

  • Use of targeted exome sequencing in genetic diagnosis of Chinese familial hypercholesterolemia
    Wu WF [2014]
  • Update of Japanese common LDLR gene mutations and their phenotypes: Mild type mutation L547V might predominate in the Japanese population
    Miyake Y [2009]
  • Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database
    Leigh SE [2008]
  • The use of next-generation sequencing in clinical diagnosis of familial hypercholesterolemia
  • The metabolic and molecular bases of inherited disease
    Scriver CR [2001]
  • The distribution and characteristics of LDL receptor mutations in China: A systematic review
    Jiang L [2015]
  • Targeted genetic testing for familial hypercholesterolaemia using next generation sequencing: a population-based study
  • Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing
    Xue Y [2015]
  • Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study
    Huxley RR [2003]
  • Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy
    Raal FJ [2011]
  • Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
    Kumar P [2009]
  • Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population
  • Mutation- Taster evaluates disease-causing potential of sequence alterations
    Schwarz JM [2010]
  • Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
    Rader DJ [2003]
  • Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population
    Yu W [2002]
  • LDL receptor mutations and ApoB mutations are not risk factors for ischemic cerebrovascular disease of the young, but lipids and lipoproteins are
  • Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
  • Identification of LDLR mutations in two Chinese pedigrees with familial hypercholesterolemia
    Yao RE [2012]
  • Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation
    Mabuchi H [2014]
  • Genetic testing of Korean familial hypercholesterolemia using whole-exome sequencing
    Han SM [2015]
  • GeneReviews(R)
    Youngblom E [2014]
  • Familial hypercholesterolemia: etiology, diagnosis and new treatment options
  • Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society
  • Ensembl 2016
    Yates A [2016]
  • Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades
    Elis A [2011]
  • Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting
  • Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China
    Chiou KR [2012]
  • Cohort profile: the Namwon study and the Dong-gu study
    Kweon SS [2014]
  • Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease
  • A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia
    Marks D [2003]
  • A receptor-mediated pathway for cholesterol homeostasis
    Brown MS [1986]
  • A method and server for predicting damaging missense mutations
    Adzhubei IA [2010]